DAvid-Blum Q2Pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR)

DAvid-Blum Q2Pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR)

About the Author

Q2 Pharma is developing small-molecule antivirulence agents against bacterial infections.

Leave a Reply